RxSight (RXST) Revenue Growth (1y) (2021 - 2026)
RxSight (RXST) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 7.30% |
| 10 | RxSight | 250.40 Mn | -153.85 Mn | - | 0.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.31% |
| Mar 31, 2026 | -18.48% |
| Dec 31, 2025 | -18.91% |
| Sep 30, 2025 | -14.09% |
| Jun 30, 2025 | -3.58% |
| Mar 31, 2025 | 28.41% |
| Dec 31, 2024 | 40.71% |
| Sep 30, 2024 | 59.08% |
| Jun 30, 2024 | 67.65% |
| Mar 31, 2024 | 68.75% |
| Dec 31, 2023 | 77.65% |
| Sep 30, 2023 | 75.97% |
| Jun 30, 2023 | 83.19% |
| Mar 31, 2023 | 95.58% |
| Dec 31, 2022 | 90.93% |
| Sep 30, 2022 | 118.03% |
| Jun 30, 2022 | 131.98% |
| Mar 31, 2022 | 156.66% |
| Dec 31, 2021 | 189.46% |
| Sep 30, 2021 | 38.75% |